Federation Des Caisses Desjardins Du Quebec I Bio, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024
SELL
$0.39 - $90.0 $2,535 - $585,000
-6,500 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.3 - $0.61 $1,950 - $3,965
6,500 New
6,500 $2.78 Million
Q2 2021

Aug 30, 2024
BUY
$1.22 - $1.65 $7,930 - $10,725
6,500 New
6,500 $9.82 Million
Q4 2020

Aug 30, 2024
SELL
$1.05 - $2.24 $2,100 - $4,480
-2,000 Reduced 23.53%
6,500 $6.83 Million
Q2 2020

Aug 30, 2024
BUY
$0.87 - $2.46 $7,395 - $20,910
8,500 New
8,500 $18.9 Million

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email